AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2020
Dec 31, 2020
32093_dirs_2020-12-30_dcc6f3db-8dfe-41e7-a7b7-d14abc6801aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-12-29
Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-29 | Common Stock | X | 376065 | $7.01 | Acquired | 11659781 | Direct |
| 2020-12-29 | Common Stock | X | 8214 | $7.01 | Acquired | 330019 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-29 | Warrant (right to buy) | $7.01 | X | 376065 | Disposed | 2025-06-15 | Common Stock (376065) | Direct |
| 2020-12-29 | Warrant (right to buy) | $7.01 | X | 8214 | Disposed | 2025-06-15 | Common Stock (8214) | Indirect |
Footnotes
F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17